Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension

Kidney International

Volumn 61, Issue 4, 2002, Pages 1462-1468

  Delles, Christian ^a   Jacobi, Johannes ^a   John, Stefan ^a   Fleischmann, Ingrid ^a   Schmieder, Roland E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Endothelium; Kidney; Nitric oxide

Indexed keywords

ENALAPRIL; EPROSARTAN; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0036226058     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00260.x     Document Type: Article

References (33)

1. Nephroprotection by antihypertensive therapy
2. Renal protection and antihypertensive drugs: Current status
3. ACE inhibition, endothelial function and coronary artery lesions. Role of kinins and nitric oxide
4. Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with congestive heart failure
5. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
6. Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
7. 1-antagonist eprosartan
8. A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure
9. Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension
10. Effect of ACE inhibition and angiotensin AT1 receptor blockade on renal and blood pressure response to L-arginine in humans
11. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension
12. Contrasting effect of antihypertensive treatment on the renal response to L-arginine
13. Measurement of renal function without urine collection. A critical evaluation of the constant-infusion-technique for determination of inulin and para-aminohippurate
14. Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure
15. Glomerular hyperfiltration during sympathetic nervous system activation in early essential hypertension
16. The renal clearance of substituted hippuric acid derivates and other aromatic acids in dogs and man
17. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients
18. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men
19. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man
20. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients
21. Renal hemodynamic effects of candesartan in normal and impaired renal function in humans
22. Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
23. Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: A review of clinical investigations
24. Effects of intra-arterial acetylcholine on renal arteriography in normal humans
25. Assessment of endothelial function of the renal vasculature in human subjects
26. Is L-arginine infusion an adequate tool to assess endothelium dependent vasodilation of the human renal vasculature?
27. Endothelial function in the human renal circulation
28. The systemic renal response to NO inhibition is not modified by angiotensin-II-receptor blockade in healthy humans
29. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans
30. Salt intake determines the renal response to L-arginine infusion in human subjects
31. Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: A double blind study
32. Studies of the renal effects of angiotensin II receptor blockade: The confounding factor of acute water loading on the action of vasoactive systems
33. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension